Abstract
Pt(C^N)(phe) (1, C^N = 2-(2′-thienyl)pyridine, phe = phenylalanine) shows a high binding affinity (ca. 106 dm3 mol−1) and selectivity towards human serum albumin (HSA) and such binding is accompanied by an enhancement of photoluminescence at 562 nm; both the protein binding affinity and cytotoxicities of [Pt(C^N)(phe) (1), Pt(C^N)(trp) (2, trp = tryptophan) and Pt(C^N)(gly) (3, gly = glycine)] are affected by the amino acid ligand with 1 having an IC50 of up to 1 μM against a number of carcinoma cell lines.
| Original language | English |
|---|---|
| Pages (from-to) | 1025-1027 |
| Number of pages | 3 |
| Journal | Chemical Communications |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 28 Feb 2005 |
Fingerprint
Dive into the research topics of 'Luminescent cyclometalated platinum(II) complexes with amino acid ligands for protein binding'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver